The Drug-Induced Cardiotoxicity Website and App

II. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)

II.m Sudden cardiac death

V. Myocarditis

V.a Myocarditis (can be fulminant)

XIV. Pleural involvement

XIV.a Pleural effusion (uni- or bilateral) (can accompany DI-LDs)

XV. Chest pain

XV.e Pleuritis (can cause chest pain)

XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis

XXIV.b Pneumonitis (ILD), acute and/or severe (may produce the ARDS pattern)

XXXVI. Autoimmune syndromes - Systemic reactions or conditions

XXXVI.b Lupus - Lupus syndrome (see also Vd)

I. Myocardial dysfunction - Heart failure

I.a Left or biventricular dysfunction/failure

II. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)

II.a Cardiac arrhythmias or dysrhythmias (AF, VT, VF, TdP)

II. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)

II.g QTc prolongation

VI. Cardiomyopathy

VI.a Cardiomyopathy (acute, subacute, chronic)

VII. Cardiotoxicity

VII.a Cardiotoxicity

X. Pulmonary edema - ALI/ARDS

X.f Capillary leak syndrome (CLS)

XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis

XXIV.a Pneumonitis (interstitial lung disease/ILD)

XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis

XXIV.c Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)

XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis

XXIV.k Organizing pneumonia pattern (an area or areas of consolidation on imaging)

XXIX. Small airway involvement

XXIX.a Bronchospasm - Wheezing - Asthma

XXXVI. Autoimmune syndromes - Systemic reactions or conditions

XXXVI.f Anaphylaxis-Anaphylactoid reaction (can be fatal)

XXXVI. Autoimmune syndromes - Systemic reactions or conditions

XXXVI.i Guillain-Barré (or GB-like) syndrome (w/wo ARF)

XXXVI. Autoimmune syndromes - Systemic reactions or conditions

XXXVI.ac Antisynthetase antibodies (ASA) - ASA syndrome

XXXVIII. Miscellaneous - Varia

XXXVIII.k Hypersensitivity reaction (may manifest with fever and/or skin, throat or airway involvement)